UCB

Overview

(Union Chimique Belge) is a multinational biopharmaceutical company based in Brussels, Belgium, founded in 1928. Initially a chemical company, it has transitioned to focus on biotechnology and pharmaceuticals, developing therapeutic solutions for severe diseases, particularly in neurology and immunology. The company specializes in treating central nervous system disorders, inflammatory and immunological conditions, and oncology.

Its product portfolio includes well-known medications such as Keppra and Vimpat for epilepsy, Cimzia for Crohn’s disease and rheumatoid arthritis, and Zyrtec for allergies. The organization invests over €1 billion annually in research and development, demonstrating a commitment to advancing innovative therapies. It serves specialist healthcare providers and institutions worldwide, with a strong presence in Europe and the United States. With reported revenues of approximately €5.3 billion in 2022, the company continues to focus on delivering solutions that meet unmet medical needs and improve patient outcomes.

Basic Information

Contact Details

• Phone: +32 2 559 99 99
• Website: ucb.com
• LinkedIn: linkedin.com/company/ucb-pharma
• Twitter: twitter.com/ucb_news
• AngelList: angel.co/ucb-pharma
• Facebook: facebook.com/ucbglobal

Key Focus Areas & Initiatives

• neurology
• immunology
• healthcare innovation beyond medicine
• biotechnology
• life sciences
• pharmaceutical manufacturing
• autoimmune diseases
• research facilities
• scientific research
• biotech manufacturing
• biotech research funding
• services
• clinical data
• medical research funding
• healthcare sustainability
• patient support
• clinical development
• autoimmune disease solutions
• patient support services
• drug efficacy
• biotech
• research funding
• biotech product development
• acquisitions
• pharmaceuticals
• supply chain
• investment in biotech
• severe disease treatments
• biotech research collaborations
• drug discovery
• drug pipeline management
• healthcare technology
• healthcare services
• regulatory approval
• biopharma r&d
• biopharma pipeline
• therapeutic areas
• healthcare access
• healthcare partnerships
• biopharmaceutical
• customer service
• severe diseases
• research
• drug manufacturing
• therapeutic innovation
• sustainability initiatives
• research centers
• regulatory compliance
• biopharma growth strategy
• medical research
• healthcare professionals
• manufacturing
• healthcare
• neuroscience drug development
• b2b
• patient outcomes
• digital transformation
• patient-focused innovation
• biopharma industry
• drug development
• innovative solutions
• healthcare innovation
• neuroscience research
• global presence
• biotech innovation hubs
• biotech sustainability
• biopharma pipeline management
• biotech industry leadership
• patient-centric
• patient engagement
• medical advancements
• medical breakthroughs
• drug pipeline
• medicines
• biotech research excellence
• medical innovation
• research and development
• therapeutic research
• biotech research
• specialized research centers
• clinical studies
• healthcare solutions
• clinical trials
• clinical research
• medical innovation culture
• product portfolio
• research excellence
• medical collaborations
• pharmaceutical and medicine manufacturing
• patient care
• manufacturing sites
• biotech innovation
• neurological conditions
• clinical trial management
• biopharma
• autoimmune therapy research
• sustainability
• biotech investment
• clinical trial innovation
• biopharma growth
• biotech venture investments
• global r&d network
• medical research collaborations
• autoimmune
• disease
• r&d
• chronic diseases
• partnerships
• peer-reviewed publications
• advanced therapies
• safety standards
• ethical practices
• patient value
• global healthcare
• pharmaceutical solutions
• genetics
• biomarkers
• sustainable practices
• health outcomes
• data transparency
• scientific advancements
• vaccines
• market intelligence
• equity story
• financial guidance
• sustainable growth
• disease areas
• health technology
• investigator-initiated studies
• patient-level data
• market access
• medical
• health care
• health, wellness & fitness
• hospital & health care
• mechanical or industrial engineering
• research & development
• environmental services
• renewables & environment

Technologies Used

• Adobe Media Optimizer
• Bootstrap Framework
• Cedexis Radar
• Data Analytics
• DoubleClick Floodlight
• Dropbox
• Facebook Login (Connect)
• Facebook Widget
• Google Analytics
• Google Maps
• Google Play
• Google Plus
• Google Tag Manager
• IoT
• Linkedin Login
• Linkedin Widget
• Micro
• Microsoft Azure Hosting
• Microsoft Office 365
• Mobile Friendly
• OneTrust
• Outlook
• React Redux
• Remote
• The Trade Desk
• Twitter Advertising
• Viewpoint
• Vimeo
• VueJS
• Webmail
• WordPress.org
• YouTube
• reCAPTCHA

Affiliated Organizations & Regional Branches

• BINPAT
• UCB Iberia
• UCB Deutschland
• UCB Australia
• UCB UK & Ireland
• R A Inc
• UCB Biopharma Brasil
• UCB US Medical
• ユーシービージャパン株式会社
• Zogenix, Inc.
• Beryllium Discovery Corp
• UCB France
• UCB Türkiye
• UCB de México
• Ucb Pharma S.P.A.